As the year wraps up, I would like to reflect on our top diversity, equity, and inclusion insights from 2024. This is especially important as we consider what more can be done to promote diversity, equity, and inclusion across the life sciences, consumer products, and retail industries. From corporate governance to health equity in clinical trials, we break down some important topics from this past year. To explore more of our DEI insights, click here.   

Top 5 Diversity, Equity, and Inclusion Insights from 2024 

1. Breaking Down DE+I Myths: Does Meritocracy Negate the Need for DE+I? 

In this four-part webinar series, Sara Morris and Caroline Hubbard give an inside look into candid data-driven conversations as we aim to dispel common DE+I myths. Whether it’s breaking down the idea that the case for DE+I is too subjective, to discussing why HR presentations alone won’t solve your DE+I challenges, our goal is to give businesses an overview of DE+I lessons learned so you can avoid them as you embark on your strategy.  

Does meritocracy negate the need for DE+I? Watch the webinar here > 

2. Building Your DEI Strategy: Mistakes to Avoid 

With DEI strategy at the top of many organizational agendas, leaders should remember that inclusion is an everyday opportunity.  As organizations look to make a greater impact, this piece by Neeki Tahssili, Sara Morris, and PK Sundar provides three common DEI strategy mistakes for organizations to avoid as they move forward.   

Learn more about common DEI strategy mistakes to avoid > 

3. Products, People, and Process: Considerations for Promoting DE+I in Retail 

Companies today are making commendable strides in updating their internal DE+I (Diversity, Equity, and Inclusion) policies. However, it’s equally crucial for these companies to extend their commitment to diversity and inclusivity to their product offerings, marketing strategy, and in-store customer experience.  In this piece, Kayla Turk and Brandon Miller outline considerations for promoting DE+I in retail with a focus on products, people, and process.   

Explore considerations for promoting DEI in retail > 

4. Drive Multicultural Engagement in Corporate Governance with these 3 Questions 

From leveraging generative AI to recruit a diverse workforce to integrating new leadership and training programs to assist with DEI initiatives, the changing approaches to DEI reflect the unique nature of today’s workforce. With 2024 being an election year and many companies experiencing “DEI fatigue,” businesses are seeking actionable steps to build on their existing efforts. Consider how your organization can drive multicultural engagement in corporate governance with these 3 questions outlined by Sara Morris, Brandon Miller, and Cherrelle Lawrence.  

Learn how to drive multicultural engagement in corporate governance > 

5. Exploring the Evolution of Health Equity in Clinical Trial Regulations 

In an ongoing evolution of equitable clinical trials, as of June 26, 2024, the FDA has issued a draft guidance, Diversity Action Plans to Improve Enrollment of Participants from Underrepresented Populations in Clinical Studies, providing new details on Diversity Action Plans required for certain clinical studies. In this piece, our DEI and clinical trials expert Brandon Miller explores the evolution of health equity in clinical trial regulations and what this evolution means for the industry moving forward.  

Read more about the evolution of health equity in clinical trial regulations > 

Learn more about our Diversity, Equity, and Inclusion (DEI) Consulting Services.